PCM
DRTS icon

Penserra Capital Management’s Alpha Tau Medical DRTS Stock Holding History

Penserra Capital Management’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,328
Closed -$20K – 1036
2022
Q2 		$20K Sell
2,328
-1,116
-32% -$9.99K ﹤0.01% 1105
2022
Q1 		$40K Buy
+3,444
New +$40.5K ﹤0.01% 1067

Other funds holding DRTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Penserra Capital Management's DRTS Position: Q3 2022 in Review

Penserra Capital Management sold out of Alpha Tau Medical (DRTS) in Q3 2022, closing a stake of 2,328 shares — an estimated $20K sold.

Penserra Capital Management first reported a position in DRTS in Q1 2022 and held it in 2 quarters. The position peaked at $40K in Q1 2022. 18 funds tracked by Wall St. Rank hold DRTS as of Q3 2022.

  • Penserra Capital Management reported no remaining Alpha Tau Medical position as of Q3 2022 after selling out during the quarter.
  • Penserra Capital Management sold 2,328 Alpha Tau Medical shares in Q3 2022, an estimated $20K.
  • Penserra Capital Management first reported a position in Alpha Tau Medical in Q1 2022 and held it in 2 quarters.
  • Penserra Capital Management's Alpha Tau Medical position peaked at $40K in Q1 2022.
  • 18 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.